Drug intelligence / Profile preview

Calonest-Plus

Development stage
Unknown
Lead developer
Prisure Medicare
Modality
Small Molecules
Administration
Oral
01

Overview

Calonest-Plus is a multi-ingredient nutritional supplement developed and marketed by Prisure Medicare, an Indian pharmaceutical company. The product is formulated as an oral soft gelatin capsule or tablet containing a combination of vitamins and minerals: elemental calcium (from calcium carbonate), Vitamin D3 (as calcitriol), methylcobalamin (Vitamin B12), L-methylfolate, Vitamin K2-7, magnesium, and zinc. It is indicated for the maintenance of bone and joint health, specifically to reduce joint inflammation and pain, enhance bone strength and flexibility, and prevent the degeneration of articular cartilage. Calonest-Plus is primarily positioned within the orthopedic therapeutic segment in the Indian market.

Brand names
Calonest-Plus
Other names
Calonest Plus
02

Targets

VDR (Vitamin D receptor)MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)

Beyond the preview

Go deeper on Calonest-Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calonest-Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call